A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Roflumilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 04 May 2012 Company added in association field as reported by ClinicalTrials.gov.
- 13 Oct 2009 New trial record.